Cisplatin chemotherapy induced TAp73 target genes specifically in BRCA1-deficient cells, and knockdown of TAp73 in these cells caused chemoresistance while having little or no effect on BRCA1-expressing tumor cells. The gene discussed is BRCA1; the disease is neoplasm.